Related Experiment Video
Updated: Aug 27, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
Published on: December 6, 2016
Persistent obstructive sleep apnoea in children: treatment options and management considerations
Refika Ersu1, Maida L Chen2, Zarmina Ehsan3
1Division of Respiratory Medicine, Children's Hospital of Eastern Ontario, Ottawa, ON, Canada; Department of Pediatrics, University of Ottawa, Ottawa, ON, Canada.
Insights
Persistent obstructive sleep apnoea (OSA) in children requires better management beyond positive airway pressure. A comprehensive approach considering diverse factors is needed for improved health outcomes.
Area of Science:
- Pediatric pulmonology
- Sleep medicine
- Public health
Background:
- Persistent obstructive sleep apnoea (OSA) after adenotonsillectomy is a growing concern in children aged 2-18.
- While linked to obesity and craniofacial issues, it also affects healthy children.
- Inadequate treatment can cause lasting negative health effects.
Purpose of the Study:
- To discuss current and novel therapeutic strategies for persistent OSA in children.
- To highlight the need for evaluating new treatments and management approaches.
- To emphasize shared decision-making and social determinants of health.
Main Methods:
- This is a Personal View article, not a primary research study.
- Discussion based on existing literature and clinical experience.
- Focus on a comprehensive, multipronged management strategy.
Main Results:
- Positive airway pressure, while effective, has low adherence rates in children.
- A broader management approach is urgently needed.
- Considering patient preferences and social determinants is crucial.
Conclusions:
- A comprehensive strategy integrating therapeutics, shared decision-making, and social determinants is essential.
- This approach may improve clinical outcomes for childhood persistent OSA.
- Promoting health equity for all children with persistent OSA is a key goal.
Abstract:
Unresolved obstructive sleep apnoea (OSA) after an adenotonsillectomy, henceforth referred to as persistent OSA, is increasingly recognised in children (2-18 years). Although associated with obesity, underlying medical complexity, and craniofacial disorders, persistent OSA also occurs in otherwise healthy children. Inadequate treatment of persistent OSA can lead to long-term adverse health outcomes beyond childhood. Positive airway pressure, used as a one-size-fits-all primary management strategy for persistent childhood OSA, is highly efficacious but has unacceptably low adherence rates. A pressing need exists for a broader, more effective management approach for persistent OSA in children. In this Personal View, we discuss the use and the need for evaluation of current and novel therapeutics, the role of shared decision-making models that consider patient preferences, and the importance of considering the social determinants of health in research and clinical practice. A multipronged, comprehensive approach to persistent OSA might achieve better clinical outcomes in childhood and promote health equity for all children.
More Related Videos
Related Concept Videos
Sleep Apnea
The condition is more prevalent among...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids
Chronic Obstructive Pulmonary Disease-V: Nursing Management
Assessment
Cardiopulmonary Resuscitation II: ACLS Airway Management
Mechanical Ventilation III: Noninvasive Ventilation
Noninvasive Positive-Pressure Ventilation...

